Institute Catalá Oncología -ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2021

  1. Ki-67 immunoexpression and radiological assessment of necrosis improves accuracy of conventional and modified core biopsy systems in predicting the final grade assigned to adult-soft tissue sarcomas. An international collaborative study

    Pathology Research and Practice, Vol. 225

2020

  1. CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer

    Translational Lung Cancer Research, Vol. 9, Núm. 4, pp. 1074-1083

2019

  1. Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted therapies using GeneReader NGS platform

    Translational Cancer Research, Vol. 8, pp. S3-S15

2018

  1. Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine–erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)

    Cancer Chemotherapy and Pharmacology, Vol. 82, Núm. 6, pp. 935-943

2017

  1. Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions

    Annals of Oncology, Vol. 28, Núm. 9, pp. 2248-2255

2016

  1. 149P: The role of CTCs and cfDNA for diagnosis and monitoring of EGFR mutations in advanced NSCLC patients

    Journal of Thoracic Oncology, Vol. 11, Núm. 4, pp. S123

2015

  1. Role of Surgery in Patients with Recurrent, Metastatic, or Unresectable Locally Advanced Gastrointestinal Stromal Tumors Sensitive to Imatinib: A Retrospective Analysis of the Spanish Group for Research on Sarcoma (GEIS)

    Annals of Surgical Oncology, Vol. 22, Núm. 9, pp. 2948-2957